Icra Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bupathi highlights key points that were presented at an OncLive Institutional Perspectives in Cancer, including implications of the EV-302 trial findings; data updates from the phase 1/2 ICRA trial; and future directions for urothelial cancer.

United statesManojkumar bupathiMountain cancer centers in littletonInstitutional perspectivesRocky mountain cancer centersEnfortumab vedotinUrothelial carcinomaTargeted therapyEv 302 trialIcra trial